No abstract

While immunotherapy holds great promise for combating cancer, the limited efficacy due to an immunosuppressive tumor microenvironment and systemic toxicity hinder the broader application of cancer immunotherapy. Here, we report a combinatorial immunotherapy approach that uses a highly efficient and tumor-selective gene carrier to improve anticancer efficacy and circumvent the systemic toxicity. In this study, we engineered tumor-targeted lipid-dendrimer-calcium-phosphate (TT-LDCP) nanoparticles (NPs) with thymine-functionalized dendrimers that exhibit not only enhanced gene delivery capacity but also immune adjuvant properties by activating the stimulator of interferon genes (STING)–cGAS pathway. TT-LDCP NPs delivered siRNA against immune checkpoint ligand PD-L1 and immunostimulatory IL-2–encoding plasmid DNA to hepatocellular carcinoma (HCC), increased tumoral infiltration and activation of CD8+ T cells, augmented the efficacy of cancer vaccine immunotherapy, and suppressed HCC progression. Our work presents nanotechnology-enabled dual delivery of siRNA and plasmid DNA that selectively targets and reprograms the immunosuppressive tumor microenvironment to improve cancer immunotherapy.

A new Eu3+-activated oxyfluoride phosphor Ca12Al14O32F2:Eu3+ (CAOF:Eu3+) was synthesized by a solid state reaction. Commonly red line emission was detected in the range of 570–700 nm. To achieve the requirement of illumination, this study revealed a crystal chemistry approach to reduce Eu ions from 3+ to 2+ in the lattice. Replacing Al3+–F– by the appreciate dopant Si4+–O2– is adopted to enlarge the activator site that enables Eu3+ to be reduced. The crystallization of samples was examined by powder X-ray diffraction (XRD) and high resolution transmission electron microscopy (HRTEM). Photoluminescence results indicated that as-synthesized phosphors Ca12Al14‑z Si z O32+z F2–z :Eu (z = 0–0.5, CASOF:Eu) display an intense blue emission peaking at 440 nm that was produced by 4f–5d transition of Eu2+, along with the intrinsic emission of Eu3+ under UV excitation. Moreover, the effect of Si4+–O2– substitution involved in the coordination environment of the activator site was investigated by further crystallographic data from Rietveld refinements. The 19F solid-state nuclear magnetic resonance (NMR) data were in agreement with refinement and photoluminescence results. Furthermore, the valence states of Eu in the samples were analyzed with the X-ray absorption near edge structure (XANES). The quantity of substituted Si4+–O2– tunes chromaticity coordinates of Ca12Al14–z Si z O32+z F2–z :Eu phosphors from (0.6101, 0.3513) for z = 0 to (0.1629, 0.0649) for z = 0.5, suggesting the potential for developing phosphors for white light emitting diodes (WLEDs). Using an activator that is valence tunable by controlling the size of the activator site represents a hitherto unreported structural motif for designing phosphors in phosphor converted light emitting diodes (pc-LEDs).

No abstract

No abstract